Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check2 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; no observable changes to the page content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This appears to be a minor version update affecting backend metadata rather than user-facing content.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; this is a minor version label and does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor versioning change that does not affect study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the site footer; this is a minor maintenance update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check90 days agoChange DetectedLocation information was updated: state locations (California, Massachusetts, Missouri, New York, Texas) were revised under Locations and the revision tag updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.6%

Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.